2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$43.85-$3.15 (-6.69%)
Price as of Oct 02, 2026 4:48 PM EDT- $1.6BMarket Cap
- -22.33%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$43.85-$3.15 (-6.69%)
NKTR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.99 | ||
Change | -$13.55 (-22.39%) | ||
Open | $55.41 | ||
High | $56.69 | ||
Low | $46.29 | ||
Previous Close | $60.55 | ||
Volume | 6,271,722 | ||
30-Day Average Volume | 1,599,841 | ||
1-Week Change | -20.87% | ||
1-Month Change | -34.51% | ||
1-Year Change | -22.33% | ||
3-Year Change | 425.97% | ||
5-Year Change | -82.98% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $1.1B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $10.1M | ||
Net Income | -$40.6M | ||
Free Cash Flow | -$75.9M | ||
EBIT | -$40.6M | ||
EBITDA | -$40.5M | ||
Net Working Capital | $668.4M | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 154 | ||
P/B | 2 | ||
P/E | -38 | ||
PEG | -1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue